Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28717776 | 1.00 | NR5A1 (0.42) | NR5A1CYP2D6SOAT1NFKB1NFKB2 | |
| SCHEMBL4201803 | 0.98 | CYP2D6 (0.41) | NR5A1CYP2D6SOAT1NFKB1NFKB2 | |
| SCHEMBL4924806 | 0.91 | CYP2D6 (0.46) | NR5A1CYP2D6NPC1LMNASMN1; SMN2 | |
| SCHEMBL4919744 | 0.84 | CYP2D6 (0.35) | CYP2D6NPC1LMNASMN1; SMN2TP53 | |
| SCHEMBL28703161 | 0.81 | CYP2D6 (0.37) | NR5A1CYP2D6NFKB1NFKB2RELA | |
| SCHEMBL27859966 | 0.80 | NR5A1 (0.44) | NR5A1CYP2D6SOAT1LMNATSHR | |
| SCHEMBL9851145 | 0.80 | NR5A1 (0.44) | NR5A1CYP2D6SOAT1LMNATSHR | |
| SCHEMBL9683872 | 0.80 | NR5A1 (0.44) | NR5A1CYP2D6SOAT1LMNATSHR | |
| SCHEMBL5187242 | 0.80 | — | — | |
| SCHEMBL25384494 | 0.79 | NR5A1 (0.47) | NR5A1SOAT1TSHRPLA2G2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687818-A1 | COMPOSITION COMPRISING AN ALKYL- AND/OR ALKENYLGLYCOSIDE | KAO CORPORATION, S.A. (ES) | 2026-02-11 | — | — | EP | disclosed |
| EP-4507666-A1 | COMPOSITION COMPRISING AN ALKYL AND/OR ALKENYLGLYCOSIDE DERIVATIVE AND AN ESTER DERIVED FROM A HYDROXYCARBOXYLIC ACID AND A FATTY ALCOHOL | KAO CORPORATION, S.A. (ES) | 2025-02-19 | — | — | EP | disclosed |
| WO-2024200480-A1 | A PROCESS FOR PREPARING A COMPOSITION COMPRISING A CARBOXYALKYLATED ALKYL- AND/OR ALKENYLGLYCOSIDE, AND THE COMPOSITION OBTAINABLE BY THIS PROCESS | KAO CHEMICALS GMBH (DE) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024200387-A1 | COMPOSITION COMPRISING AN ALKYL- AND/OR ALKENYLGLYCOSIDE | KAO CORPORATION S.A. (ES) | 2024-10-03 | — | — | WO | disclosed |
| WO-2023198731-A1 | COMPOSITION COMPRISING AN ALKYL AND/OR ALKENYLGLYCOSIDE DERIVATIVE AND AN ESTER DERIVED FROM A HYDROXYCARBOXYLIC ACID AND A FATTY ALCOHOL | KAO CORPORATION, S.A.U (ES) | 2023-10-19 | — | — | WO | disclosed |
| US-20230129036-A1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| WO-2022067414-A1 | PHOTOSTABLE COMPOSITION AND METHOD OF REDUCING OR CONTROLLING WEED POPULATION APPLYING SAID COMPOSITION | UPL DO BRASIL INDUSTRIA E COMERCIO DE INSUMOS AGROPECUARIOS S.A. (BR) | 2022-04-07 | — | — | WO | disclosed |
| CN-102470087-B | Ester mixtures and compositions comprising such ester mixtures | COGNIS IP MAN GMBH | 2015-07-15 | — | — | CN | disclosed |
| CN-102238936-B | Skin whitener | COGNIS IP MAN GMBH | 2014-09-17 | — | — | CN | disclosed |
| CN-101325942-B | Personal care compositions | PROCTER & GAMBLE | 2013-06-26 | — | — | CN | disclosed |
| WO-2010138710-A2 | TOPICAL SKIN CARE COMPOSITIONS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2010-12-02 | — | — | WO | disclosed |
| CN-101675912-A | cosmetic and dermatological formulations containing phenoxyalkyl esters | EVONIK GOLDSCHMIDT GMBH | 2010-03-24 | — | — | CN | disclosed |
| CN-101610792-A | Keratin-binding effector molecules and methods for producing same by coupling keratin-binding polypeptides to effector molecules carrying carboxyl or sulfonic acid groups | BASF AG (DE) | 2009-12-23 | — | — | CN | disclosed |
| CN-101203207-A | Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides with active and effect agents, preparation thereof and use thereof in the cosmetic industry | BASF AG (DE) | 2008-06-18 | — | — | CN | disclosed |
| CN-101193950-A | Fragrance alcohol-releasing polysiloxane | DEGUSSA (DE) | 2008-06-04 | — | — | CN | disclosed |
| CN-101115835-A | CpG-ODN (oligodeoxynucleotide) having stem loops and flanking sequences without CpG motifs for treating skin disorders | PHENION GMBH & CO KG (DE) | 2008-01-30 | — | — | CN | disclosed |
| CN-1853602-A | Long time stable cosmetic emulsion | GOLDSCHMIDT GMBH (DE) | 2006-11-01 | — | — | CN | disclosed |
| CN-1212826-C | Topical skin preparation containing idebenone with protecting and regenerating effects | NEUDECKER BIRGIT (DE) | 2005-08-03 | — | — | CN | disclosed |
| CN-1359285-A | Topical skin preparation containing idebenone with protecting and regenerating effects | NEUDECKER BIRGIT (DE) | 2002-07-17 | — | — | CN | disclosed |
| CN-1291468-A | Condensed benzene derivative used as antioxidant or free radical scavenger and its use in cosmetic preparations | BASF AG (DE) | 2001-04-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230129036-A1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | HPD, CYP4A22, PAH | NR5A1 615/4885CYP2D6 84/4885SOAT1 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.